JeffreyWardCooneyMD

Neurology • Durham, NC

Duke Neurology Movement Disorders Center

Join to view full profile

Dr. Cooney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Cooney's full profile

Already have an account?

Office
932 Morreene Rd
Durham, NC 27705
Phone+1 919-668-7600
Is this information wrong?

Education & Training

University of North Carolina HospitalsFellowship, Neuromuscular Medicine (Neurology), 2014 - 2015
University of North Carolina HospitalsResidency, Neurology, 2010 - 2014
University of North Carolina at Chapel Hill School of MedicineClass of 2010

Certifications & Licensure

NC State Medical License 2014 - 2024
American Board of Psychiatry and Neurology Neurology

Clinical Trials

SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE) Start of enrollment: 2014 Dec 22
Completed
Phase 2
A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214 Start of enrollment: 2016 Jan 01
Active, not recruiting
Phase 1
Study of Urate Elevation in Parkinson's Disease, Phase 3 Start of enrollment: 2016 Jun 01
Completed
Phase 3
Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease Start of enrollment: 2018 Jan 10
Terminated
Phase 2
BTRX-246040 Study in Subjects With Parkinson's Disease With Motor Fluctuations Start of enrollment: 2018 Aug 31
Completed
Phase 2
Closed Loop DBS Implanted RC+S Study Start of enrollment: 2019 Jul 10
Active, not recruiting
Not Applicable
Rostock International Parkinson's Disease Study (ROPAD) Start of enrollment: 2019 May 30
Recruiting
Trial of Parkinson's And Zoledronic Acid Start of enrollment: 2019 Nov 15
Recruiting
Phase 4
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations Start of enrollment: 2019 Sep 30
Active, not recruiting
Phase 3
Flexible-Dose Trial in Early Parkinson's Disease (PD) Start of enrollment: 2020 Jan 06
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Viewpoint on Milestones for Fellowship Training in Movement Disorders.
Jeffrey B Ratliff, Sara M Schaefer, Shilpa Chitnis, Jeffrey W Cooney, Christopher W Hess, Njideka Okubadejo, Ali Shalash, Elena Moro, Carolyn Sue, Sanjay Pandey, Pramo...> ;Movement Disorders. 2022 Aug 1
6 citations
Initial Clinical Outcome With Bilateral, Dual-Target Deep Brain Stimulation Trial in Parkinson Disease Using Summit RC + S.
Kyle T Mitchell, Stephen L Schmidt, Jeffrey W Cooney, Warren M Grill, Jennifer Peters, Shervin Rahimpour, Hui-Jie Lee, Sin-Ho Jung, Sneha Mantri, Burton Scott, Shivana...> ;Neurosurgery. 2022 Jul 1
12 citations
Telemedicine and Deep brain stimulation - Current practices and recommendations.
Vibhash D. Sharma, Delaram Safarpour, Shyamal H. Mehta, Nora Vanegas-Arroyave, Daniel Weiss, Jeffrey W. Cooney, Zoltan Mari, Alfonso Fasano> ;Parkinsonism & Related Disorders. 2021 Jul 8
6 citations
Mindfulness based stress reduction in people with Parkinson's disease and their care partners.
Deepal P Shah-Zamora, Allison M. Allen, Lacy Rardin, Margaret Ivancic, Katie Durham, Patrick Hickey, Jeffrey W. Cooney, Burton L. Scott, Sneha Mantri> ;Complementary Therapies in Clinical Practice. 2021 Mar 31
1 citations
Levodopa inhalation powder in a patient with persistent asthma
Chris Gillette, Jeffrey W. Cooney, Caroline Bell Sisson, Nicole Rockich-Winston, Courtney J. Perry, Wendy C. Moore> ;Parkinsonism & Related Disorders. 2020 Jul 14
1 citations
Corrigendum: Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: An expert consensus (CNS Spectrums (2018) 23:6 (40...
Kevin J. Black, Henry Nasrallah, Stuart Isaacson, Mark Stacy, Rajesh Pahwa, Charles H. Adler, Gustavo Alva, Jeffrey W. Cooney, Daniel Kremens, Matthew Menza, Johnathan...> ;CNS Spectrums. 2019 Oct 1
4 citations
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus.
Kevin J Black, Henry Nasrallah, Stuart Isaacson, Mark Stacy, Rajesh Pahwa, Charles H Adler, Gustavo Alva, Jeffrey W Cooney, Daniel Kremens, Matthew A Menza, Jonathan M...> ;CNS Spectrums. 2018 Dec 1
5 citations
Corticobasal syndrome in a man with Gaucher disease type 1: Expansion of the understanding of the neurological spectrum
Lauren B. Flueckinger, Stephanie DeArmey, Roy N. Alcalay, Jeffrey W. Cooney, Priya S. Kishnani, Kunal C. Potnis> ;Molecular Genetics and Metabolism Reports. 2018 Oct 18
56 citations
Neuropsychiatric Issues in Parkinson’s Disease
Jeffrey W. Cooney, Mark Stacy> ;Current Neurology and Neuroscience Reports. 2016 Apr 5
164 citations
Hierarchical cognitive control deficits following damage to the human frontal lobe
David Badre, Joshua N. Hoffman, Jeffrey W. Cooney, Mark D'Esposito> ;Nature Neuroscience. 2009 Mar 1
197 citations
Functional Interactions between Prefrontal and Visual Association Cortex Contribute to Top-Down Modulation of Visual Processing
Adam Gazzaley, Jesse Rissman, Jeffrey W. Cooney, Aaron M. Rutman, Tyler M. Seibert, Wesley C. Clapp, Mark D'Esposito> ;Cerebral Cortex. 2007 Sep 1
67 citations
Age-related deficits in component processes of working memory
Adam Gazzaley, Margaret A. Sheridan, Jeffrey W. Cooney, Mark D'Esposito> ;Neuropsychology. 2007 Sep 1
50 citations
Is the Prefrontal Cortex Necessary for Delay Task Performance? Evidence from Lesion and fMRI Data
Mark D'Esposito, Jeffrey W. Cooney, Adam Gazzaley, Sasha E. B. Gibbs, Bradley R. Postle> ;Journal of the International Neuropsychological Society. 2006 Mar 1
650 citations
Top-down suppression deficit underlies working memory impairment in normal aging
Adam Gazzaley, Jeffrey W. Cooney, Jesse Rissman, Mark D'Esposito> ;Nature Neuroscience. 2005 Sep 11
331 citations
Top-down Enhancement and Suppression of the Magnitude and Speed of Neural Activity
Adam Gazzaley, Jeffrey W. Cooney, Kevin McEvoy, Robert T. Knight, Mark D'Esposito> ;Journal of Cognitive Neuroscience. 2005 Apr 1
27 citations
Neurological disorders and the structure of human consciousness
Jeffrey W. Cooney, Michael S. Gazzaniga> ;Trends in Cognitive Sciences. 2003 Apr 1
Join now to see all

Journal Articles

Case Report Corticobasal Syndrome in a Man with Gaucher Disease Type 1: Expansion of the Understanding of the Neurological Spectrum
Priya S Kishnani, Jeffrey W Cooney, Roy N Alcalay, Stephanie M DeArmey, ScienceDirect